Small biotech firm Novavax said in a press release that it has made 'progress in its efforts to develop a novel vaccine to protect against coronavirus disease.'
Small biotech firm Novavax said in a press release Wednesday that it has made"progress in its efforts to develop a novel vaccine to protect against coronavirus disease."Novavax said it is looking at several vaccine candidates for animals and hopes to be able to narrow them down to find"an optimal candidate for human testing, which is expected to begin by the end of spring 2020." Shares of Novavax soared nearly 20% Wednesday on the news.
Read MoreAnother small US biotech company named Moderna said late Monday that it has already shipped an experimental vaccine to the National Institute of Allergy and Infectious Diseases for testing. Shares of Moderna soared 20% Wednesday, following a more-than-25% spike Tuesday.Gilead Sciences drug remdesivir may help treat coronavirus symptoms, according to WHOThe best possible hope for a coronavirus treatment might actually come from biotech giant Gilead Sciences .
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Biotech company Moderna says its coronavirus vaccine is ready for initial testsUS biotech firm Moderna has shipped an experimental coronavirus vaccine to US government researchers just six weeks after it started working on the immunization.
Les mer »
Biotech company Moderna says its coronavirus vaccine is ready for first testsThe first vials of an experimental vaccine for novel coronavirus are ready for human testing
Les mer »
Dashboard of a downturn: coronavirus starts to set off some recession alarm bellsWill China's coronavirus outbreak send the world economy into recession?
Les mer »
Health insurer shares pummeled by Sanders surge, virus worriesAs concerns over the spreading coronavirus outbreak hammered U.S. stocks, one co...
Les mer »